WCM
SNY icon

Wallace Capital Management’s Sanofi SNY Stock Holding History

Wallace Capital Management’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-106,734
Closed -$5.19M – 81
2024
Q1 		$5.19M Sell
106,734
-6,372
-6% -$311K 0.71% 22
2023
Q4 		$5.62M Sell
113,106
-5,655
-5% -$277K 0.84% 22
2023
Q3 		$6.37M Sell
118,761
-5,882
-5% -$314K 0.98% 20
2023
Q2 		$6.72M Sell
124,643
-550
-0.4% -$29.6K 1.04% 22
2023
Q1 		$6.81M Sell
125,193
-2,508
-2% -$122K 1.12% 20
2022
Q4 		$6.18M Sell
127,701
-4,505
-3% -$198K 0.97% 23
2022
Q3 		$5.03M Sell
132,206
-7,309
-5% -$326K 0.84% 25
2022
Q2 		$7.27M Sell
139,515
-1,339
-1% -$71.1K 1.1% 23
2022
Q1 		$7.47M Sell
140,854
-1,735
-1% -$89.6K 1.13% 24
2021
Q4 		$7.14M Sell
142,589
-4,715
-3% -$233K 1% 24
2021
Q3 		$7.1M Sell
147,304
-11,286
-7% -$574K 0.96% 25
2021
Q2 		$8.35M Sell
158,590
-960
-0.6% -$50.1K 1.1% 23
2021
Q1 		$8.09M Buy
159,550
+399
+0.3% +$19.2K 1.06% 23
2020
Q4 		$7.73M Sell
159,151
-6,990
-4% -$345K 1.17% 21
2020
Q3 		$8.34M Sell
166,141
-6,640
-4% -$342K 1.46% 15
2020
Q2 		$8.82M Sell
172,781
-2,208
-1% -$107K 1.61% 17
2020
Q1 		$7.65M Sell
174,989
-756
-0.4% -$36.2K 1.47% 15
2019
Q4 		$8.82M Sell
175,745
-4,900
-3% -$230K 1.21% 23
2019
Q3 		$8.37M Sell
180,645
-5,445
-3% -$235K 1.1% 26
2019
Q2 		$8.05M Sell
186,090
-639
-0.3% -$27.2K 1.06% 27
2019
Q1 		$8.27M Buy
186,729
+6,990
+4% +$299K 1.14% 26
2018
Q4 		$7.8M Sell
179,739
-3,525
-2% -$155K 1.13% 26
2018
Q3 		$8.19M Buy
183,264
+1,619
+0.9% +$69.2K 1.04% 29
2018
Q2 		$7.27M Buy
181,645
+5,340
+3% +$210K 0.97% 29
2018
Q1 		$7.07M Buy
176,305
+23,980
+16% +$998K 1.01% 28
2017
Q4 		$6.55M Buy
152,325
+2,236
+1% +$103K 1% 26
2017
Q3 		$7.47M Buy
150,089
+7,995
+6% +$387K 1.2% 22
2017
Q2 		$6.81M Buy
142,094
+3,550
+3% +$170K 1.09% 23
2017
Q1 		$6.27M Buy
138,544
+2,665
+2% +$113K 1.07% 24
2016
Q4 		$5.5M Sell
135,879
-1,815
-1% -$71.5K 1% 25
2016
Q3 		$5.26M Buy
137,694
+4,400
+3% +$177K 0.93% 27
2016
Q2 		$5.58M Buy
133,294
+8,389
+7% +$344K 0.92% 25
2016
Q1 		$5.02M Buy
124,905
+4,530
+4% +$182K 0.89% 26
2015
Q4 		$5.13M Buy
120,375
+2,265
+2% +$104K 0.98% 26
2015
Q3 		$5.61M Buy
118,110
+6,860
+6% +$349K 1.03% 25
2015
Q2 		$5.51M Buy
111,250
+2,385
+2% +$121K 0.96% 24
2015
Q1 		$5.38M Buy
108,865
+8,561
+9% +$409K 0.95% 24
2014
Q4 		$4.58M Buy
100,304
+8,990
+10% +$436K 0.88% 26
2014
Q3 		$5.15M Buy
91,314
+2,684
+3% +$144K 1.06% 24
2014
Q2 		$4.71M Buy
88,630
+4,871
+6% +$259K 0.99% 26
2014
Q1 		$4.38M Buy
83,759
+2,030
+2% +$103K 0.96% 27
2013
Q4 		$4.38M Buy
81,729
+2,075
+3% +$107K 1.01% 28
2013
Q3 		$4.03M Buy
79,654
+1,790
+2% +$91.1K 1.11% 27
2013
Q2 		$4.01M Buy
+77,864
New +$4.15M 1.21% 26

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wallace Capital Management's SNY Position: Q2 2024 in Review

Wallace Capital Management sold out of Sanofi (SNY) in Q2 2024, closing a stake of 106,734 shares — an estimated $5.19M sold.

Wallace Capital Management first reported a position in SNY in Q2 2013 and held it in 44 quarters. The position peaked at $8.82M in Q4 2019. 729 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

  • Wallace Capital Management reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
  • Wallace Capital Management sold 106,734 Sanofi shares in Q2 2024, an estimated $5.19M.
  • Wallace Capital Management first reported a position in Sanofi in Q2 2013 and held it in 44 quarters.
  • Wallace Capital Management's Sanofi position peaked at $8.82M in Q4 2019.
  • 729 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on Wallace Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.